William Michael Kavanaugh Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William Michael Kavanaugh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William Michael Kavanaugh. William Michael Kavanaugh is a SVP & Chief Scientific Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and a Chief Scientific Officer and in CytomX Therapeutics, Inc. ($CTMX) and a CSO, Head Res.&Non-Clin. Dev. in CytomX Therapeutics, Inc. ($CTMX).
Address: C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO 94080 CA
Companies in which William Michael Kavanaugh is an Insider
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William Michael Kavanaugh: Chief Scientific Officer and, CSO, Head Res.&Non-Clin. Dev.
Holdings: 19,047 shares
Current Value: $219,041
Latest Transaction: Feb 19 2020
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William Michael Kavanaugh: SVP & Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 26 2014
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of William Michael Kavanaugh
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2020 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | A | 7.13 | 120,000 | 855,600 | 120,000 | |
| Jan 29 2019 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | A | 16.85 | 90,000 | 1,516,500 | 90,000 | |
| Jan 26 2018 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | A | 25.82 | 75,000 | 1,936,500 | 75,000 | |
| Dec 12 2017 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | M | 1.57 | 5,130 | 8,079 | 240,912 | |
| Dec 12 2017 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Buy | M | 1.57 | 5,130 | 8,079 | 19,047 | 13.9 K to 19 K (+36.86 %) |
| Oct 06 2017 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | M | 4.47 | 48,368 | 216,340 | 48,368 | |
| Oct 06 2017 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Sell | S | 24.34 | 48,368 | 1,177,277 | 13,917 | 62.3 K to 13.9 K (-77.66 %) |